Protalix BioTherapeutics, Inc. (DE) financial statements, including revenue, expenses, and profit
The total revenue of PLX for the last quarter is 18.22 M USD, and it's 1.44% higher compared to the previous quarter. The net income of Q4 24 is 6.49 M USD.